METHYLPHENIDATE AMONG MEDICAL STUDENTS: ETHICAL CHALLENGES AND HEALTH HARMS.

Abstract

The study investigates the non-prescribed use of methylphenidate among medical students, highlighting
the ethical dilemmas involved and the associated health risks. Methylphenidate, a central nervous system
stimulant, is approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) but is often
improperly used to enhance academic performance. This usage is particularly common among medical
students, who resort to the drug to improve concentration and increase resistance to fatigue during
periods of high academic pressure. The study is based on an integrative literature review, analyzing
empirical and theoretical studies published over the last five years. The consulted databases include
MEDLINE, LILACS, and PubMed, using descriptors related to methylphenidate and stimulant use. The
research reveals that the intense pressure to achieve high academic performance, combined with the
easy availability of methylphenidate and the belief that the drug provides a competitive edge, are factors
that encourage its use among students. However, several adverse effects have been observed, such as
insomnia, anxiety, psychological dependence, mood alterations, and other health problems. The study
concludes that while methylphenidate use is common, it poses significant risks to the physical and
mental health of students. The research recommends awareness campaigns about the dangers of
indiscriminate drug use and suggests the implementation of stricter regulatory strategies to control
access to the medication.